Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ologen Collagen Matrix

K-Number: K173223 · 2018-03-02

Decision Date2018-03-02
Product CodeKGN
DecisionSubstantially Equivalent

Device Summary

ologen Collagen Matrix is a medical device manufactured by Aeon Astron Europe B.V.. It received FDA 510(k) clearance on 2018-03-02 under approval number K173223. The device is classified under product code KGN. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ologen Collagen Matrix?

ologen Collagen Matrix is a medical device that received FDA 510(k) clearance on 2018-03-02. It is manufactured by Aeon Astron Europe B.V.. The 510(k) number is K173223.

When was ologen Collagen Matrix approved by the FDA?

ologen Collagen Matrix received FDA 510(k) clearance on 2018-03-02, under approval number K173223.

What company makes ologen Collagen Matrix?

ologen Collagen Matrix is manufactured by Aeon Astron Europe B.V..

What is the FDA product code for ologen Collagen Matrix?

The FDA product code for ologen Collagen Matrix is KGN.

Related Clinical Trials

Related Devices (Code: KGN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.